C Nord1, A Mykletun, S D Fosså. 1. Department of Clinical Cancer Research, University Hospital, The Norwegian Radiumhospital, Montebello, N-0310 Oslo, Norway. carina.nord@klinmed.uio.no
Abstract
BACKGROUND: The aim of the study was to evaluate Norwegian cancer patients' awareness of their prior cancer diagnosis in a general population-based study. METHODS: A cross-sectional population-based study of cancer patients' responses to the index question: 'Do you have or have you had cancer?' was carried out. We assessed correctness of the response in relation to cancer site, date of diagnosis, marital status, age and education. Smoking was chosen as a marker of health awareness. A total of 65,330 persons participated in the Nord-Trøndelag Health Survey (HUNT-II), performed in 1995-1997. The database of HUNT-II was merged with the Cancer Registry of Norway (CRN), thus identifying each of the 2983 (4 percent) participants with an invasive cancer diagnosis. RESULTS: Excluding basal cell epithelioma, a total of 20 percent of the patients denied their prior cancer diagnosis. This group consisted mainly of men (54 percent) and those who were diagnosed as very young or as elderly. More smokers than non-smokers were unaware of their prior malignancy (24 percent versus 20 percent). CONCLUSIONS: A 20 percent rate of patients who denied their former malignancy is surprisingly and unacceptably high. Disclosure of a cancer diagnosis should help the patient to develop increased health awareness. It should enable a person to report his or her former cancer diagnosis when necessary.
BACKGROUND: The aim of the study was to evaluate Norwegian cancerpatients' awareness of their prior cancer diagnosis in a general population-based study. METHODS: A cross-sectional population-based study of cancerpatients' responses to the index question: 'Do you have or have you had cancer?' was carried out. We assessed correctness of the response in relation to cancer site, date of diagnosis, marital status, age and education. Smoking was chosen as a marker of health awareness. A total of 65,330 persons participated in the Nord-Trøndelag Health Survey (HUNT-II), performed in 1995-1997. The database of HUNT-II was merged with the Cancer Registry of Norway (CRN), thus identifying each of the 2983 (4 percent) participants with an invasive cancer diagnosis. RESULTS: Excluding basal cell epithelioma, a total of 20 percent of the patients denied their prior cancer diagnosis. This group consisted mainly of men (54 percent) and those who were diagnosed as very young or as elderly. More smokers than non-smokers were unaware of their prior malignancy (24 percent versus 20 percent). CONCLUSIONS: A 20 percent rate of patients who denied their former malignancy is surprisingly and unacceptably high. Disclosure of a cancer diagnosis should help the patient to develop increased health awareness. It should enable a person to report his or her former cancer diagnosis when necessary.
Authors: Jacqueline Casillas; Karen L Syrjala; Patricia A Ganz; Emy Hammond; Alfred C Marcus; Kerry M Moss; Catherine M Crespi; Peiyun Lu; Mary S McCabe; Jennifer S Ford; Linda A Jacobs; Donna Pucci; Steven C Palmer; Amanda M Termuhlen; Lisa Diller; Marci Campbell; Barbara Jones; Debra L Friedman Journal: J Cancer Surviv Date: 2011-11-02 Impact factor: 4.442
Authors: Nina Byskosh; Vivek Pamulapati; Shujun Xu; Ashley K Vavra; Andrew W Hoel; Lu Tian; Mary M McDermott; Zeeshan Butt; Karen J Ho Journal: J Vasc Surg Date: 2021-11-15 Impact factor: 4.268
Authors: Martin Mueller; Stefanie Lohmann; Paul Thul; Arved Weimann; Eva Grill Journal: Health Qual Life Outcomes Date: 2010-04-16 Impact factor: 3.186